Animal models represent essential tools for dissecting the molecular mechanisms of CD4+ T-lymphocyte depletion, a process central to immunopathogenesis in HIV-1-infected humans. The goal of this application is to increase our understanding of primate immunodeficiency virus replication and pathogenicity, using chimeric viruses containing genetic segments of HIV-1 (tat, rev, vpu and env) in an SIV/mac background. Infection of macaques with certain of these simian-human immunodeficiency viruses (SHIVs) resembles HIV-1 infection of humans in the course of acute viral replication as well as in the elicitation of cellular and humoral immune responses. Moreover, some SHIVs cause rapid and specific CD4+ T-lymphocyte depletion in monkeys, with subsequent development of AIDS-like illnesses and death. Molecularly cloned SHIVs that replicate efficiently in rhesus macaques but differ in CD4-depleting ability have been identified and studied. Our results indicate that the exterior domains of the HIV-1 envelopes glycoproteins determine the efficiency with which CD4+ T-lymphocytes are depleted in the animals, independently of effects on virus replication in vivo. Two phenotypes have been identified for the more pathogenic env segments: increased ability to mediate membrane fusion and resistance to neutralizing antibodies.
The specific aims of this proposal are: 1. To identify the HIV env sequences associated with increased fusogenicity and with neutralization resistance, and to determine which of these phenotypes is more critical for CD4+ T-lymphocyte-depleting ability in SHIV-infected macaques. 2. To determine whether the HIV-1 envelope glycoprotein fusogenic capacity per se contributes to rapid CD4+ T-lymphocyte-depleting ability, independently of effects on SHIV replication in vivo. 3. To determine whether syncytium formation contributes to rapid CD4+ T-lymphocyte depletion in SHIV-infected macaques. 4. To evaluate the in vivo role of the HIV-1 specific Vpu protein in acute SHIV replication and CD4+ T-lymphocyte depletion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI033832-08
Application #
6199421
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (03))
Program Officer
Plaeger, Susan F
Project Start
1993-04-01
Project End
2005-05-30
Budget Start
2000-06-15
Budget End
2001-05-31
Support Year
8
Fiscal Year
2000
Total Cost
$481,191
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Song, Byeongwoon; Cayabyab, Mark; Phan, Ngoc et al. (2004) Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease. Virology 322:168-81
Cayabyab, Mark; Rohne, Daniela; Pollakis, Georgios et al. (2004) Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate. AIDS Res Hum Retroviruses 20:27-40
Etemad-Moghadam, B; Rhone, D; Steenbeke, T et al. (2001) Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J Virol 75:5646-55
Liao, H X; Etemad-Moghadam, B; Montefiori, D C et al. (2000) Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains. J Virol 74:254-63
LaBonte, J A; Patel, T; Hofmann, W et al. (2000) Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells. J Virol 74:10690-8
Reimann, K A; Watson, A; Dailey, P J et al. (1999) Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses. Virology 256:15-21
Etemad-Moghadam, B; Sun, Y; Nicholson, E K et al. (1999) Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo. J Virol 73:8873-9
Cayabyab, M; Karlsson, G B; Etemad-Moghadam, B A et al. (1999) Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J Virol 73:976-84
Chen, Z W; Zhou, D; Chalifoux, L et al. (1997) Disseminated granulomatous disease in a simian immunodeficiency virus- and bacille Calmette-Guerin-infected rhesus monkey. AIDS 11:266-7
Li, A; Baba, T W; Sodroski, J et al. (1997) Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses 13:647-56

Showing the most recent 10 out of 21 publications